Which segment is expected to dominate the ozempic market in 2025
Best practice recommendations include: Comprehensive assessment before initiating any weight-loss medication, including cardiovascular screening, mental health evaluation, and review of current medications Monotherapy first : Trying one evidence-based medication at an appropriate dose before considering alternatives Regular monitoring : Scheduled follow-up appointments to assess weight loss, side effects, blood pressure, heart rate, and overall wellbeing Diabetes monitoring : For patients with diabetes, regular review of HbA1c/glucose levels and adjustment of insulin or sulfonylureas as needed to prevent hypoglycaemia Lifestyle integration : Ensuring medication is used alongside dietary changes, physical activity, and behavioural support Individualised treatment plans : Tailoring approaches to patient-specific factors, comorbidities, and preferences If you are considering weight-loss medication or are currently taking Mounjaro or phentermine, schedule a thorough consultation with your GP or a specialist in obesity medicine
The approval of semaglutide is based on part 1 of the ESSENCE phase 3 clinical trial, with full approval contingent on the confirmation of efficacy and safety outcomes from part 2 of the same study
Reach out to PlexusDx support before your tripyour provider can address storage concerns and ensure continuity of care while you're away
In Trial 8, one of the CV outcomes trials, 891 (56%) patients treated with semaglutide tablets were 65 years of age and over and 200 (13%) patients treated with semaglutide tablets were 75 years of age and over
Just sharing
